Latest News for: Cambridge discovery

Edit

MARKET REPORT: Morrisons bidding battle sends shares soaring to their highest level since 2013 at 273p

The Daily Mail 02 Aug 2021
Shares in hit their highest level since 2013 yesterday as investors prepared for a bidding war between two private equity groups ... RELATED ARTICLES. Previous 1 2 Next ... BUSINESS CLOSE ... Share ... Merger Monday was in full swing and showed no signs of abating with Cambridge antibody firm Abcam snapping up a Californian drug discovery biotech for £245 million ... .
Edit

Movers & Shakers: Abrams named CFO at Arch Therapeutics

Metrowest Daily News 01 Aug 2021
Sigal joined BMS in 1997 and held roles in both discovery and development before ascending to chief scientific officer and president of R&D ... Chase Carpenter of Cambridge, term expiring 2023; Ari Freisinger of San Francisco, California, term expiring 2023; and Deborah Merkin of Wellesley, term expiring 2021.
Edit

Researchers Reverse Memory Loss in Mice

Kayhan 30 Jul 2021
LONDON (Dispatches) -- Age-related memory loss in mice has been successfully reversed and the discovery can lead to the development of treatments to prevent memory loss in people as they age, Cambridge and Leeds scientists report. Scientists at the University of Cambridge and ...
Edit

Scientists reverse age-related memory loss in mice

Technology Org 30 Jul 2021
Scientists at Cambridge and Leeds have successfully reversed age-related memory loss in mice and say their discovery could lead to the development of treatments to prevent memory loss in people as they age ... Professor James Fawcett from the John van Geest Centre for Brain Repair at the University of Cambridge said ... University of Cambridge.
Edit

Birmingham cancer project enters Immuno-oncology Alliance

Pharmiweb 29 Jul 2021
... new therapeutic targets.  Projects are structured to ensure rapid outputs, university-based scientists direct the discovery work in basic biology, and Cancer Research UK scientists based in London and Cambridge support this while working in parallel on the chemistry.
Edit

Macomics, the Macrophage-based Drug Discovery company, secures £4.24m expansion financing, and appoints CEO, CSO and ...

The Marshall News Messenger 29 Jul 2021
Steve began his career at Cancer Research Technology, responsible for identifying new academic drug discovery opportunities in Cambridge UK and was latterly Head of Alliances, Business Development, establishing multiple drug discovery partnerships between Pharma, biotech and academia.
Edit

Macomics, the Macrophage-based Drug Discovery company, secures £4.24m expansion financing, and appoints CEO, CSO and VP Immunology

Pharmiweb 29 Jul 2021
... Co-founder Dr Luca Cassetta to move from his academic role at Edinburgh University to join as full-time VP Immunology Funds will accelerate macrophage-based therapeutics R&D portfolio and target discovery capability; expansion of facilities in Edinburgh and Cambridge.
Edit

Abata Therapeutics Strengthens Board of Directors

The Marshall News Messenger 28 Jul 2021
– a Cambridge biotechnology company focused on the discovery and development of a novel class of medicines that modulate signaling by protein growth factors to treat musculoskeletal, fibrotic diseases, and cancer ... Abata is based in Cambridge, Mass.
Edit

She Changed Astronomy Forever. He Won the Nobel Prize For It.

Democratic Underground 28 Jul 2021
In 1967, Burnell made a discovery that altered our perception of the universe ... student at Cambridge University assisting the astronomer Anthony Hewish, she discovered pulsars — compact, spinning celestial objects that give off beams of radiation, like cosmic lighthouses ... .
Edit

Mayo Clinic and nference Study Links Pre-Existing Conditions to Short- and Long-Term COVID-19 Complications

Daily Times Chronicle 27 Jul 2021
This powerful AI technology, frequently implemented by nference during the COVID-19 pandemic, has enabled discoveries with a wide range of implications that contribute to a greater understanding of the virus and the disease, which are ultimately advancing patient care.
Edit

Q-State Biosciences Awarded NIH Grant for the Development of ASO Therapies Targeting Cancer Pain

The Marshall News Messenger 20 Jul 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 20, 2021--. (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of epilepsy, pain, and ... Q-State Biosciences is a discovery technology and therapeutics company based in Cambridge, Massachusetts.
Edit

NIMIUM Therapeutics and Paraza Pharma form partnership to develop new medicines to treat cardiometabolic diseases ...

The Philadelphia Tribune 20 Jul 2021
Paraza Pharma, a Montreal Canada and Cambridge Massachusetts, USA, based company is an integrated preclinical drug discovery organization with focus on excellence in science and innovation.
Edit

Rivus Pharmaceuticals Launches with $35 Million Series A Financing to Develop Novel Treatments for Cardio-Metabolic Diseases

Johnson City Press 20 Jul 2021
The round was co-led by Longitude Capital and Medicxi and RxCapital also participated. "More than 40 million people in the U.S ... About Rivus Pharmaceuticals ... For more information, please visit . About Longitude Capital ... RxCapital is the venture capital arm of RxCelerate, a leading international out-sourced drug discovery platform based in Cambridge, UK ... .
Edit

Movers & Shakers

Metrowest Daily News 18 Jul 2021
He holds degrees from BYU-Idaho and Longy School of Music of Bard College in Cambridge ... Sigal joined BMS in 1997 and held roles in both discovery and development before ascending to chief scientific officer and president of R&D ... At Colantonio, he is assigned to the Roosevelt Towers Low-Rise Modernization project for the Cambridge Housing Authority.
Edit

PAQ Therapeutics Launches with $30 Million Series A to Develop Novel Therapies through Autophagy-Dependent Degradation

Daily Times Chronicle 15 Jul 2021
CAMBRIDGE, Mass., July 15, 2021 /PRNewswire/ -- PAQ Therapeutics, a biotechnology company pioneering a new approach to ... Based in Cambridge, Massachusetts, the global PAQ team collectively brings decades of drug discovery experience and significant expertise in autophagy research.

Most Viewed

×